In 2017, about 31.4 percent of the prescription medicine sold were generic drugs. This share is expected to reach about 38.9 percent by 2027. The value of generic drug sales is forecasted to reach about 567 million U.S. dollars by that year.
Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$189 USD $149 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Expenditure on pharmaceuticals in Sweden 2009-2022
- Premium Statistic Number of novel drugs approved annually by CDER 2008-2022
- Basic Statistic Key measurements of U.S. CDER drug approvals in 2022
- Basic Statistic U.S. opinions on insurance coverage of personalized tests and treatments in 2018
- Basic Statistic Major concerns among adults regarding personalized medicine in the U.S. in 2018
- Basic Statistic U.S. adults that have not heard of personalized medicine 2018
- Basic Statistic Reactions among U.S. adults to description of personalized medicine 2018
- Premium Statistic Leading MS pharmaceutical drugs in the U.S. by revenue 2013
- Basic Statistic Expenditure on prescription pharmaceuticals in Sweden 2009-2022
- Basic Statistic Expenditure on nonprescription pharmaceuticals in Sweden 2009-2022
About the region
10
- Premium Statistic Pharmaceutical market value Singapore 2017-2022
- Premium Statistic Industrial production index pharmaceuticals biological products Singapore 2013-2022
- Premium Statistic Output value of pharmaceutical and biological industry Singapore 2013-2022
- Premium Statistic Industrial production index of chemicals and chemical products Singapore 2013-2022
- Premium Statistic Production facilities for pharmaceutical and biological products Singapore 2012-2021
- Premium Statistic FDI earnings for pharmaceutical and biological products Singapore 2012-2021
- Premium Statistic Industrial production index of leather products Singapore 2013-2022
- Premium Statistic Industrial production index rubber and plastic products Singapore 2013-2022
- Premium Statistic Industrial production index of wearing apparel Singapore 2013-2022
- Premium Statistic Industrial production index of wood and cork products Singapore 2011-2021
Selected statistics
6
- Premium Statistic Medicinal market growth worldwide including rebates 2009-2018
- Premium Statistic Expenditure worldwide on diabetes by market 2013-2018
- Basic Statistic AstraZeneca's revenue from top product Pulmicort 2006-2022
- Premium Statistic Standard Unit medicine use per capita in the U.S. 2007-2011
- Premium Statistic Chinese insulin market distribution: leading companies 2011
- Premium Statistic U.S. insulin market distribution: leading companies 2011
Other regions
10
- Premium Statistic Top 50 pharmaceutical companies - Rx sales and R&D spending 2022
- Basic Statistic Production value of pharmaceutical products & preparations in Sweden 2012-2020
- Premium Statistic U.S. mail pharmacies ranked by Rx drugs market share 2014 and 2022
- Basic Statistic Leading pharmaceutical imports to Germany 2021, by country of origin
- Basic Statistic Public drug program spending in Canada by therapy share 2021
- Basic Statistic Value of local pharmaceutical products in Turkey 2010-2022
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2022
- Premium Statistic Pharmaceutical products: wholesale value growth rate France 2005-2019
- Basic Statistic Antidepressants pharmaceutical consumption in Portugal 2009-2022
- Basic Statistic Cardiovascular system daily pharmaceutical consumption in Iceland 2008-2021
Related statistics
10
- Premium Statistic FDI stock for pharmaceutical and biological products Singapore 2012-2021
- Premium Statistic R&D spending on biomedical and related sciences in Singapore 2019, by sector
- Premium Statistic Industrial production index of refined petroleum products Singapore 2013-2022
- Premium Statistic Industrial production index of paper and paper products Singapore 2013-2022
- Premium Statistic Number of clinical trials approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product manufacturers approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product importers approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product exporters approved Singapore 2017-2022
- Premium Statistic Number of licenses for health product wholesalers approved Singapore 2017-2022
- Premium Statistic Expected value added biomedical manufacturing Singapore 2017-2021
Further related statistics
10
- Sanofi's total assets 2007-2022
- Merck & Co - expenditure on research and development 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- GSK's operating profit by division 2006-2021
- Merck & Co total assets 2009-2022
- Key figures on established biotech centers worldwide 2012-2016
- MorphoSys' revenue 2006-2022
- MorphoSys' research & development expenditure 2006-2022
- Merck & Co cash dividends declared 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
Further Content: You might find this interesting as well
Statistics
- Sanofi's total assets 2007-2022
- Merck & Co - expenditure on research and development 2006-2022
- Pfizer's revenues in the U.S. and abroad 2009-2022
- GSK's operating profit by division 2006-2021
- Merck & Co total assets 2009-2022
- Key figures on established biotech centers worldwide 2012-2016
- MorphoSys' revenue 2006-2022
- MorphoSys' research & development expenditure 2006-2022
- Merck & Co cash dividends declared 2006-2022
- AstraZeneca's expenditure on research and development 2006-2022
Singapore Business Review. (May 1, 2018). Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027 [Graph]. In Statista. Retrieved September 30, 2023, from https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/
Singapore Business Review. "Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027." Chart. May 1, 2018. Statista. Accessed September 30, 2023. https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/
Singapore Business Review. (2018). Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027. Statista. Statista Inc.. Accessed: September 30, 2023. https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/
Singapore Business Review. "Share of Generic Drugs on The Prescription Medicine Sales Market in Singapore in 2017 and a Forecast for 2027." Statista, Statista Inc., 1 May 2018, https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/
Singapore Business Review, Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027 Statista, https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/ (last visited September 30, 2023)
Share of generic drugs on the prescription medicine sales market in Singapore in 2017 and a forecast for 2027 [Graph], Singapore Business Review, May 1, 2018. [Online]. Available: https://www.statista.com/statistics/1119548/singapore-generic-drugs-share-of-prescription-medicine-sales/